{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:36:21Z","timestamp":1778582181745,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Das follikul\u00e4re Schilddr\u00fcsenkarzinom (FTC) ist die zweith\u00e4ufigste Form des differenzierten Schilddr\u00fcsenkarzinoms und macht etwa 5\u201315\u202f% aller Schilddr\u00fcsenmalignome aus. Das FTC wird gem\u00e4\u00df der WHO(World Health Organization)-Klassifikation von 2022 in drei Subtypen gegliedert, die sich in Gesamtprognose und Rezidivwahrscheinlichkeit deutlich unterscheiden. Dar\u00fcber hinaus ist die Kenntnis gutartiger follikul\u00e4rer Tumoren und Low-grade-Neoplasien wichtig. Prognostische Faktoren bei den malignen Ver\u00e4nderungen sind neben dem Lebensalter, die Gr\u00f6\u00dfe des Tumors, invasives Wachstum, das Vorliegen von Angioinvasionen sowie das Vorhandensein von Fernmetastasen. Die chirurgische Vorgehensweise orientiert sich an diesen Faktoren. Entsprechend unterscheidet sie sich zwischen den Subtypen des FTC. Eine genaue Kenntnis der einzelnen Subtypen von Schilddr\u00fcsentumoren ist erforderlich, um eine individuell angemessene chirurgische Therapieentscheidung treffen zu k\u00f6nnen.<\/jats:p>","DOI":"10.1007\/s00104-025-02276-1","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T13:38:03Z","timestamp":1743341883000},"page":"544-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Update follikul\u00e4res Schilddr\u00fcsenkarzinom\u00a0\u2013 Was ist f\u00fcr Chirurg*innen relevant?","Update on follicular thyroid cancer\u2014What is relevant for surgeons?"],"prefix":"10.1007","volume":"96","author":[{"given":"Nicolas","family":"Schlegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"9","key":"2276_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/thy.2023.0141","volume":"33","author":"SZ Ali","year":"2023","unstructured":"Ali\u00a0SZ, Baloch\u00a0ZW, Cochand-Priollet\u00a0B, Schmitt\u00a0FC, Vielh\u00a0P, VanderLaan\u00a0PA (2023) The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid 33(9):1039\u20131044. https:\/\/doi.org\/10.1089\/thy.2023.0141","journal-title":"Thyroid"},{"issue":"2","key":"2276_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/PAS.0b013e318267aee6","volume":"37","author":"T Antic","year":"2013","unstructured":"Antic\u00a0T, Taxy\u00a0JB (2013) Thyroid frozen section: supplementary or unnecessary? Am J Surg Pathol 37(2):282\u2013286. https:\/\/doi.org\/10.1097\/PAS.0b013e318267aee6","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2276_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/SLA.0b013e3181a77b7b","volume":"249","author":"R Asari","year":"2009","unstructured":"Asari\u00a0R, Koperek\u00a0O, Scheuba\u00a0C, Riss\u00a0P, Kaserer\u00a0K, Hoffmann\u00a0M, Niederle\u00a0B (2009) Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a\u00a0prospectively collected, retrospectively analyzed clinical trial. Ann Surg 249(6):1023\u20131031. https:\/\/doi.org\/10.1097\/SLA.0b013e3181a77b7b","journal-title":"Ann Surg"},{"issue":"1","key":"2276_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch\u00a0ZW, Asa\u00a0SL, Barletta\u00a0JA, Ghossein\u00a0RA, Juhlin\u00a0CC, Jung\u00a0CK, Mete\u00a0O (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33(1):27\u201363. https:\/\/doi.org\/10.1007\/s12022-022-09707-3","journal-title":"Endocr Pathol"},{"issue":"5","key":"2276_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai\u00a0L, Zafereo\u00a0M, Cabanillas\u00a0ME (2024) Thyroid cancer: a\u00a0review. JAMA 331(5):425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA"},{"key":"2276_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040712","author":"T Chiba","year":"2024","unstructured":"Chiba\u00a0T (2024) Molecular pathology of thyroid tumors: essential points to comprehend regarding the latest WHO classification. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12040712","journal-title":"Biomedicines"},{"issue":"1","key":"2276_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/hed.25356","volume":"41","author":"JB Choi","year":"2019","unstructured":"Choi\u00a0JB, Lee\u00a0SG, Kim\u00a0MJ, Kim\u00a0TH, Ban\u00a0EJ, Lee\u00a0CR, Park\u00a0CS (2019) Oncologic outcomes in patients with 1\u2011cm to 4\u2011cm differentiated thyroid carcinoma according to extent of thyroidectomy. Head Neck 41(1):56\u201363. https:\/\/doi.org\/10.1002\/hed.25356","journal-title":"Head Neck"},{"key":"2276_CR8","doi-asserted-by":"publisher","first-page":"723394","DOI":"10.3389\/fendo.2021.723394","volume":"12","author":"JF de Leijer","year":"2021","unstructured":"de Leijer\u00a0JF, Metman\u00a0MJH, van der Hoorn\u00a0A, Brouwers\u00a0AH, Kruijff\u00a0S, van Hemel\u00a0BM, Westerlaan\u00a0HE (2021) Focal thyroid Incidentalomas on (18)F-FDG PET\/CT: a\u00a0systematic review and meta-analysis on prevalence, risk of malignancy and inconclusive Fine needle aspiration. Front Endocrinol 12:723394. https:\/\/doi.org\/10.3389\/fendo.2021.723394","journal-title":"Front Endocrinol"},{"issue":"2","key":"2276_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00423-013-1140-z","volume":"399","author":"G Dionigi","year":"2014","unstructured":"Dionigi\u00a0G, Kraimps\u00a0JL, Schmid\u00a0KW, Hermann\u00a0M, Sheu-Grabellus\u00a0SY, De Wailly\u00a0P, Sessa\u00a0F (2014) Minimally invasive follicular thyroid cancer (MIFTC)\u2014a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 399(2):165\u2013184. https:\/\/doi.org\/10.1007\/s00423-013-1140-z","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"2276_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00423-013-1057-6","volume":"398","author":"H Dralle","year":"2013","unstructured":"Dralle\u00a0H, Musholt\u00a0TJ, Schabram\u00a0J, Steinmuller\u00a0T, Frilling\u00a0A, Simon\u00a0D (2013) German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398(3):347\u2013375. https:\/\/doi.org\/10.1007\/s00423-013-1057-6 (the German Thyroid Cancer Patient Support Organization Ohne Schilddruse leben e, V.)","journal-title":"Langenbecks Arch Surg"},{"issue":"8","key":"2276_CR11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1089\/thy.2023.0327","volume":"34","author":"SP Ginzberg","year":"2024","unstructured":"Ginzberg\u00a0SP, Sharpe\u00a0J, Passman\u00a0JE, Amjad\u00a0W, Wirtalla\u00a0CJ, Soegaard Ballester\u00a0JM, Wachtel\u00a0H (2024) Revisiting the relationship between tumor size and risk in well-differentiated thyroid cancer. Thyroid 34(8):980\u2013989. https:\/\/doi.org\/10.1089\/thy.2023.0327","journal-title":"Thyroid"},{"issue":"3","key":"2276_CR12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cncr.30360","volume":"123","author":"BR Haugen","year":"2017","unstructured":"Haugen\u00a0BR (2017) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer 123(3):372\u2013381. https:\/\/doi.org\/10.1002\/cncr.30360","journal-title":"Cancer"},{"issue":"1","key":"2276_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen\u00a0BR, Alexander\u00a0EK, Bible\u00a0KC, Doherty\u00a0GM, Mandel\u00a0SJ, Nikiforov\u00a0YE, Wartofsky\u00a0L (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"5","key":"2276_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1507\/endocrj.ej12-0419","volume":"60","author":"Y Ito","year":"2013","unstructured":"Ito\u00a0Y, Hirokawa\u00a0M, Masuoka\u00a0H, Yabuta\u00a0T, Kihara\u00a0M, Higashiyama\u00a0T, Miyauchi\u00a0A (2013) Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr\u00a0J 60(5):637\u2013642. https:\/\/doi.org\/10.1507\/endocrj.ej12-0419","journal-title":"Endocr J"},{"issue":"5","key":"2276_CR15","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3803\/EnM.2022.1553","volume":"37","author":"CK Jung","year":"2022","unstructured":"Jung\u00a0CK, Bychkov\u00a0A, Kakudo\u00a0K (2022) Update from the 2022 world health organization classification of thyroid tumors: a\u00a0standardized diagnostic approach. Endocrinol Metab 37(5):703\u2013718. https:\/\/doi.org\/10.3803\/EnM.2022.1553","journal-title":"Endocrinol Metab"},{"issue":"4","key":"2276_CR16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/lary.30441","volume":"133","author":"N Kethidi","year":"2023","unstructured":"Kethidi\u00a0N, Vedula\u00a0S, Shihora\u00a0D, Patel\u00a0R, Park\u00a0RCW (2023) Extent of surgery for follicular thyroid carcinoma. Laryngoscope 133(4):993\u2013999. https:\/\/doi.org\/10.1002\/lary.30441","journal-title":"Laryngoscope"},{"issue":"1","key":"2276_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamaoncol.2020.5935","volume":"7","author":"MJ Livhits","year":"2021","unstructured":"Livhits\u00a0MJ, Zhu\u00a0CY, Kuo\u00a0EJ, Nguyen\u00a0DT, Kim\u00a0J, Tseng\u00a0CH, Yeh\u00a0MW (2021) Effectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a\u00a0randomized clinical trial. JAMA Oncol 7(1):70\u201377. https:\/\/doi.org\/10.1001\/jamaoncol.2020.5935","journal-title":"JAMA Oncol"},{"issue":"5","key":"2276_CR18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/01.sla.0000186421.30982.d2","volume":"242","author":"CY Lo","year":"2005","unstructured":"Lo\u00a0CY, Chan\u00a0WF, Lam\u00a0KY, Wan\u00a0KY (2005) Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242(5):708\u2013715. https:\/\/doi.org\/10.1097\/01.sla.0000186421.30982.d2","journal-title":"Ann Surg"},{"issue":"12","key":"2276_CR19","first-page":"5255","volume":"29","author":"F Lumachi","year":"2009","unstructured":"Lumachi\u00a0F, Borsato\u00a0S, Tregnaghi\u00a0A, Marino\u00a0F, Polistina\u00a0F, Basso\u00a0SM, Fassina\u00a0A (2009) FNA cytology and frozen section examination in patients with follicular lesions of the thyroid gland. Anticancer Res 29(12):5255\u20135257","journal-title":"Anticancer Res"},{"issue":"3","key":"2276_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.17849\/insm-47-03-143-158.1","volume":"47","author":"AF Milano","year":"2018","unstructured":"Milano\u00a0AF (2018) Thyroid cancer: 20-year comparative mortality and survival analysis of six thyroid cancer histologic subtypes by age, sex, race, stage, cohort entry time-period and disease duration (SEER*stat 8.3.2) A systematic review of 145,457 cases for diagnosis years 1993\u20132013. J\u00a0Insur Med 47(3):143\u2013158. https:\/\/doi.org\/10.17849\/insm-47-03-143-158.1","journal-title":"J Insur Med"},{"issue":"2","key":"2276_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejso.2010.11.005","volume":"37","author":"CJ O\u2019Neill","year":"2011","unstructured":"O\u2019Neill\u00a0CJ, Vaughan\u00a0L, Learoyd\u00a0DL, Sidhu\u00a0SB, Delbridge\u00a0LW, Sywak\u00a0MS (2011) Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol 37(2):181\u2013185. https:\/\/doi.org\/10.1016\/j.ejso.2010.11.005","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2276_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41379-021-00907-6","volume":"35","author":"H Park","year":"2022","unstructured":"Park\u00a0H, Shin\u00a0HC, Yang\u00a0H, Heo\u00a0J, Ki\u00a0CS, Kim\u00a0HS, Kim\u00a0TH (2022) Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations. Mod Pathol 35(2):186\u2013192. https:\/\/doi.org\/10.1038\/s41379-021-00907-6","journal-title":"Mod Pathol"},{"key":"2276_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12957-015-0612-8","volume":"13","author":"M Podda","year":"2015","unstructured":"Podda\u00a0M, Saba\u00a0A, Porru\u00a0F, Reccia\u00a0I, Pisanu\u00a0A (2015) Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors. World J Surg Oncol 13:193. https:\/\/doi.org\/10.1186\/s12957-015-0612-8","journal-title":"World J Surg Oncol"},{"key":"2276_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174467","author":"P Seifert","year":"2021","unstructured":"Seifert\u00a0P, Schenke\u00a0S, Zimny\u00a0M, Stahl\u00a0A, Grunert\u00a0M, Klemenz\u00a0B, Gorges\u00a0R (2021) Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a\u00a0Region with Long History of Iodine Deficiency: A\u00a0German Multicenter Trial. Cancers. https:\/\/doi.org\/10.3390\/cancers13174467","journal-title":"Cancers"},{"key":"2276_CR25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae581","author":"MT Stegenga","year":"2024","unstructured":"Stegenga\u00a0MT, Oudijk\u00a0L, van Velsen\u00a0EFS, Peeters\u00a0RP, Medici\u00a0M, Verburg\u00a0FA, Visser\u00a0WE (2024) Impact of reclassification of oncocytic and follicular thyroid carcinoma by the 2022 WHO classification. J\u00a0Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae581","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2276_CR26","doi-asserted-by":"publisher","first-page":"e2334","DOI":"10.1210\/clinem\/dgae084","volume":"109","author":"MT Stegenga","year":"2024","unstructured":"Stegenga\u00a0MT, van Velsen\u00a0EFS, Oudijk\u00a0L, Verburg\u00a0FA, van Ginhoven\u00a0TM, Peeters\u00a0RP, van Kemenade\u00a0FJ (2024) Clinical and histopathological risk factors for radioactive iodine-refractory follicular and oncocytic thyroid carcinoma. J\u00a0Clin Endocrinol Metab 109(12):e2334\u2013e2341. https:\/\/doi.org\/10.1210\/clinem\/dgae084","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2276_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","volume":"5","author":"DL Steward","year":"2019","unstructured":"Steward\u00a0DL, Carty\u00a0SE, Sippel\u00a0RS, Yang\u00a0SP, Sosa\u00a0JA, Sipos\u00a0JA, Nikiforov\u00a0YE (2019) Performance of a\u00a0multigene genomic classifier in thyroid nodules with indeterminate cytology: a\u00a0prospective blinded multicenter study. JAMA Oncol 5(2):204\u2013212. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4616","journal-title":"JAMA Oncol"},{"issue":"5","key":"2276_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","volume":"14","author":"FN Tessler","year":"2017","unstructured":"Tessler\u00a0FN, Middleton\u00a0WD, Grant\u00a0EG, Hoang\u00a0JK, Berland\u00a0LL, Teefey\u00a0SA, Stavros\u00a0AT (2017) ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J\u00a0Am Coll Radiol 14(5):587\u2013595. https:\/\/doi.org\/10.1016\/j.jacr.2017.01.046","journal-title":"J Am Coll Radiol"},{"issue":"20","key":"2276_CR29","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1002\/cncr.26085","volume":"117","author":"D Vriens","year":"2011","unstructured":"Vriens\u00a0D, de Wilt\u00a0JH, van der Wilt\u00a0GJ, Netea-Maier\u00a0RT, Oyen\u00a0WJ, de Geus-Oei\u00a0LF (2011) The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117(20):4582\u20134594. https:\/\/doi.org\/10.1002\/cncr.26085","journal-title":"Cancer"},{"issue":"1","key":"2276_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00259-013-2546-0","volume":"41","author":"A Wale","year":"2014","unstructured":"Wale\u00a0A, Miles\u00a0KA, Young\u00a0B, Zammit\u00a0C, Williams\u00a0A, Quin\u00a0J, Dizdarevic\u00a0S (2014) Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules. Eur J Nucl Med Mol Imaging 41(1):105\u2013115. https:\/\/doi.org\/10.1007\/s00259-013-2546-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2276_CR31","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-24-0146","author":"H Yamazaki","year":"2024","unstructured":"Yamazaki\u00a0H, Sugino\u00a0K, Katoh\u00a0R, Matsuzu\u00a0K, Kitagawa\u00a0W, Nagahama\u00a0M, Ito\u00a0K (2024) Management of follicular thyroid carcinoma. Eur Thyroid\u00a0J. https:\/\/doi.org\/10.1530\/ETJ-24-0146","journal-title":"Eur Thyroid J"},{"issue":"3","key":"2276_CR32","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12020-023-03466-9","volume":"82","author":"T Zhang","year":"2023","unstructured":"Zhang\u00a0T, He\u00a0L, Wang\u00a0Z, Dong\u00a0W, Sun\u00a0W, Zhang\u00a0P, Zhang\u00a0H (2023) Risk factors for death of follicular thyroid carcinoma: a\u00a0systematic review and meta-analysis. Endocrine 82(3):457\u2013466. https:\/\/doi.org\/10.1007\/s12020-023-03466-9","journal-title":"Endocrine"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-025-02276-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-025-02276-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-025-02276-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T07:53:59Z","timestamp":1750924439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-025-02276-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2276"],"URL":"https:\/\/doi.org\/10.1007\/s00104-025-02276-1","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"28 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Schlegel gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}